financetom
Business
financetom
/
Business
/
Vistara passengers can travel paperless from Bengaluru airport thanks to biometric tech
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vistara passengers can travel paperless from Bengaluru airport thanks to biometric tech
Jul 23, 2019 8:27 AM

The Kempegowda International Airport in Bengaluru has successfully launched the ‘Early Go Live’ of its ambitious Digi Yatra project, a fully biometric-based self-boarding solution for a seamless flow from registration to boarding.

The airport launched the Vision-Box developed and installed One-ID biometric platform technology in partnership with Vistara that will enable passengers to breeze through the Bengaluru airport, a press release said.

Once completed by the beginning of next year, it is expected to be the largest deployment of an end-to-end paperless biometric programme in Asia with over 350 passenger touchpoints at Bengaluru Airport Terminal 1.

“BIAL is extremely excited to roll out this Digi Yatra-based biometric technology that has the potential to make the passenger experience at the BLR Airport seamless, secure and enjoyable. As the gateway to a new India, the BLR Airport would like to be a frontrunner amongst next-generation airport operations," said Hari Marar, MD and CEO of Bangalore International Airport Ltd.

In its initial phase, the programme will enable passengers travelling on Vistara flight UK864 from Bengaluru to Mumbai to utilise this facility without presenting travel documents at every touchpoint.

This, the release said, was made possible by the integration of Vistara’s Departure Control System with the technology, allowing effortless processing at the entry to the terminal, passenger security screening and the boarding gate. It is also expected that all Vistara flights will be integrated into the biometric boarding process by October.

First Published:Jul 23, 2019 5:27 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Prospera Energy Announced Monthly Operations Update and Increase to Term Loan
Prospera Energy Announced Monthly Operations Update and Increase to Term Loan
Dec 18, 2024
09:19 AM EST, 12/18/2024 (MT Newswires) -- Prospera Energy Inc. ( GXRFF ) , trading at 52 week lows, on Wednesday began to publish monthly production reports, designed to provide stakeholders with consistent, timely insights into operational performance and key field developments. Among highlights provided in its first report it noted November field production was estimated at 686 boe per...
CommScope Soars Over 23% After $4.15 Billion Debt Refinancing Deal: Details
CommScope Soars Over 23% After $4.15 Billion Debt Refinancing Deal: Details
Dec 18, 2024
CommScope Holding Company, Inc. ( COMM ) shares are trading higher premarket today. On Tuesday, the company completed a comprehensive refinancing with its first-lien secured lenders. As part of the refinancing, CommScope ( COMM ) secured agreements with existing first-lien lenders, including Apollo and Monarch Alternative Capital. The transaction includes a $3.15 billion first-lien term loan maturing in 2029 and...
Oklo Stock Is Surging Wednesday Morning: What's Going On?
Oklo Stock Is Surging Wednesday Morning: What's Going On?
Dec 18, 2024
Oklo Inc ( OKLO ) shares are trading higher Wednesday. The Sam Altman-backed nuclear startup announced a long-term agreement to provide advanced nuclear power for an AI, cloud and data center provider. What Happened: Oklo ( OKLO ) on Wednesday said it signed a non-binding Master Power Agreement with Switch to deploy 12 gigawatts of Oklo Aurora powerhouse projects through...
Krystal Biotech Says Initial Results From Kyanite-1 Trial Show 'Early Evidence' of Monotherapy Activity
Krystal Biotech Says Initial Results From Kyanite-1 Trial Show 'Early Evidence' of Monotherapy Activity
Dec 18, 2024
09:23 AM EST, 12/18/2024 (MT Newswires) -- Krystal Biotech ( KRYS ) said Wednesday that preliminary results from its Kyanite-1 clinical trial showed early evidence of monotherapy activity that was mostly seen in participants with advanced non-small cell lung cancer. The company is evaluating inhaled KB707, a modified HSV-1 vector, to treat solid tumors in the lung, it added. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved